Published in Klin Med (Mosk) on July 01, 1973
[Experimenting with the use of L-asparaginase in the treatment of neoplasms of the blood system]. Klin Med (Mosk) (1973) 0.84
[Richter's syndrome: analysis of literature data and original observations]. Ter Arkh (1999) 0.80
[Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease]. Ter Arkh (2004) 0.79
Chromosomes in acute leukemia. Hum Genet (1979) 0.78
Chromosomal characteristics of malignant lymphoma. Hum Genet (1989) 0.77
[Stomach MALT-lymphoma with marked plasmocytic differentiation: a variant of Mott's cell tumor]. Arkh Patol (2004) 0.77
Ultrastructural criteria of malignancy of adrenal medullary tumor. Bull Exp Biol Med (2002) 0.76
[In vitro activity of surgical suture materials containing cephalosporin antibiotics]. Antibiot Khimioter (1994) 0.76
[Differential diagnosis of Wegener's granulomatosis and extranodal NK/T-cell lymphoma, nasal type]. Ter Arkh (2012) 0.76
[Unusual morphological picture of the blast crisis in chronic myeloleukemia]. Probl Gematol Pereliv Krovi (1980) 0.75
[The clinical characteristics of hematosarcoma with primary skin involvement]. Ter Arkh (1989) 0.75
[Lymphoproliferative disorders and Sjögren's syndrome]. Ter Arkh (1978) 0.75
[Cytomorphological differentiation diagnosis and evaluation of p53mut, bcl-2, CD95 in peripheral B-cell small cell lymphomas]. Arkh Patol (2000) 0.75
[Changes in the variant of acute leukemia]. Ter Arkh (1984) 0.75
[The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas]. Ter Arkh (1996) 0.75
[Immunoblastic lymphosarcoma in chronic lympholeukemia and prolymphocytic lymphosarcoma (Richter's syndrome)]. Arkh Patol (1988) 0.75
[Clinico-morphological variants of acute leukemia]. Probl Gematol Pereliv Krovi (1969) 0.75
[Enzymatic profile of spleen cells in murine amyloidosis]. Biull Eksp Biol Med (1971) 0.75
[Immunoblastic lymphosarcoma]. Arkh Patol (1982) 0.75
[Results of cooperative clinical study of the new antineoplastic antibiotic, bruneomycin]. Antibiotiki (1968) 0.75
Blastomogenic activity of p-hydroxyphenyllactic acid in mice. Cancer Res (1975) 0.75
[Epithelial membrane antigen in lymphosarcoma cells (immunomorphologic study)]. Arkh Patol (1992) 0.75
Surface leukaemic antigen and malignancy of cells in mice infected with Mazurenko virus. Nature (1970) 0.75
Two different anti-erythroid monoclonal antibodies in immunodiagnosis of human leukemias: a comparative study. Int J Cancer (1989) 0.75
[The treatment procedure in olfactory (esthesioneurogenic) tumors]. Vopr Onkol (1991) 0.75
[Immune response to Epstein-Barr virus terminal repeat protein in patients with undifferentiated nasopharyngeal cancer]. Biull Eksp Biol Med (1995) 0.75
[Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma]. Arkh Patol (1996) 0.75
[Aminopeptidases in cells of non-Hodgkin's lymphoma of varying degrees of malignancy and in lymphogranulomatosis]. Arkh Patol (1997) 0.75
[The first experience of using rituximab in Mikulicz disease]. Ter Arkh (2010) 0.75
[Differential diagnosis of rheumatic diseases and blood cancers involving the nasal cavity and accessory sinuses]. Ter Arkh (2014) 0.75
[Preliminary results of clinical trial of the antineoplastic antibiotic bruneomycin]. Antibiotiki (1967) 0.75
[The immunology of CD4-negative skin hematosarcomas]. Vestn Dermatol Venerol (1989) 0.75
[Large-cell anaplastic lymphoma Ki-I]. Klin Lab Diagn (1997) 0.75
[Modern aspects of treatment of acute leukemia]. Vestn Akad Med Nauk SSSR (1968) 0.75
[Autoimmune hemopathies]. Ter Arkh (1967) 0.75
[Pathological anatomy of Lennert's lymphoma]. Arkh Patol (1985) 0.75
[Clinical morphological comparisons in neuroleukemia]. Klin Med (Mosk) (1976) 0.75
[Clinical aspects of lymphoblastic and prolymphocytic lymphosarcoma]. Ter Arkh (1978) 0.75
[Specific surface leukemic antigen and malignization of cells in mice of CC57BR strain innoculated with Mazurenko virus]. Biull Eksp Biol Med (1970) 0.75
[Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma]. Arkh Patol (2005) 0.75
[Mitotic regimen of different histological variants of lymphosarcoma]. Arkh Patol (1981) 0.75
[Leukemization of hematosarcomas with primary involvement of the skin]. Ter Arkh (1988) 0.75
[Lymphosarcoma with paraproteinemia]. Ter Arkh (1980) 0.75
[Main principles and diagnostic criteria of "Reevaluation of the European-American classification of lymphoid tumors"]. Arkh Patol (1997) 0.75
[Diagnosis of visceral leishmaniasis]. Arkh Patol (1994) 0.75
[The role of parotid gland biopsy in early detection of lymphoma in primary Sjogren's syndrome]. Ter Arkh (2009) 0.75
[Hairy cell leukemia with specific omental involvement]. Ter Arkh (1996) 0.75
Reactivity of anti-macrophage monoclonal antibody D11 in human leukemia and malignant lymphoma. Int J Cancer (1996) 0.75
[MALT gastric lymphoma--principles of morphological diagnosis]. Arkh Patol (2003) 0.75
[Myeloma disease developing into acute plasma cell leukemia]. Probl Gematol Pereliv Krovi (1976) 0.75
[Clinico-morphological characteristics of prolymphocytic variants of lymphosarcoma]. Ter Arkh (1981) 0.75
[Ultrastructural characteristics of the lymph node cells in lympho- and reticulosarcomas]. Arkh Patol (1977) 0.75
[Expression of argyrophilic proteins from the nucleolar organizer regions as an index of maturity degree of benign and malignant adrenal tumors]. Arkh Patol (2004) 0.75
[Angiofollicular hyperplasia of the neck lymph nodes]. Vopr Onkol (1982) 0.75
[Diagnosis of chronic lymphoid leukemia (an immunomorphological study)]. Arkh Patol (2003) 0.75
[Clinical and morphological aspects of MALT-gastric lymphoma]. Eksp Klin Gastroenterol (2010) 0.75
[Urinary purines and uric acid excretion in patients with various blood contents of cobalamin compounds]. Probl Gematol Pereliv Krovi (1970) 0.75
[Localization of fibrin in human tumors]. Arkh Patol (1969) 0.75
[Morphological manifestations of large cell anaplastic Ki1(CD30)-positive lymphoma in children]. Arkh Patol (2000) 0.75
[Importance of proliferative potential (as the ratio of a proliferative cells number and duration of mitosis) in diagnoses of malignant degree and prognosis of adrenocortical cancer]. Arkh Patol (2012) 0.75
[Results of the polychemotherapy of different variants of lymphosarcomas based on the World Health Organization classification]. Gematol Transfuziol (1983) 0.75
[Several perspectives and ways of using cytochemical methods of study in oncology]. Arkh Patol (1970) 0.75
[Immunoblastic lymphadenitis: pathohistologic picture and differential diagnosis from malignant lymphoma]. Arkh Patol (1996) 0.75
[Ultrastructure of the lymph node cells in hyperplasia and lymphosarcoma]. Probl Gematol Pereliv Krovi (1977) 0.75
[Iron metabolism in Marchiafava-Micheli syndrome]. Probl Gematol Pereliv Krovi (1967) 0.75
[Angiofollicular hyperplasia of the retroperitoneal lymph nodes (two cases)]. Vopr Onkol (1983) 0.75
[The morphological diagnosis of malignant non-Hodgkin's lymphomas (lymphosarcomas)]. Arkh Patol (1990) 0.75
[Hodgkin lymphoma with lymphoid predominance: differential diagnosis of nodular lymphoid predominance and classical variant]. Arkh Patol (2003) 0.75
[Possibility of using histo- and cytochemical determination of phosphorylase in the diagnosis of breast tumors]. Arkh Patol (1967) 0.75
[The possibility of retrospective diagnosis of enzymopenic hemolytic anemia]. Klin Med (Mosk) (1968) 0.75
[Angioimmunoblastic lymphadenopathy]. Ter Arkh (1979) 0.75
[Case of disseminated intravascular coagulation in lymphoblastic leukemia]. Klin Med (Mosk) (1978) 0.75
[Diagnosis of anaplastic large-cell lymphoma]. Arkh Patol (2006) 0.75
[Dermatofibrosarcoma protuberans]. Arkh Patol (1976) 0.75
[Differential diagnostic and prognostic significance of the activity of nucleolar organizer region in non-Hodgkin's malignant lymphoma]. Klin Lab Diagn (1997) 0.75
[Mantle cell lymphoma]. Arkh Patol (2002) 0.75
[Use of pyrogenal in the evaluation of granulocyte reserve of the bone marrow]. Vopr Onkol (1968) 0.75
[Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease]. Arkh Patol (2000) 0.75
[Pathologic anatomy of subtypes of immunoblastic lymphosarcoma]. Arkh Patol (1989) 0.75
Cytochemical studies of skeleton neoplasms. Folia Histochem Cytochem (Krakow) (1970) 0.75
[Morphoimmunohistochemical differential diagnosis of B-cell lymphomas]. Arkh Patol (2006) 0.75
[Current treatment of lymphogranulomatosis]. Vopr Onkol (1970) 0.75
[Pathology of mitosis in clinical oncomorphology]. Arkh Patol (1984) 0.75
[Histoenzymologic methods in differential diagnosis of benign and malignant tumors in human]. Vestn Akad Med Nauk SSSR (1968) 0.75
[Immunohistochemical identification of hormonally-inactive tumors of the adrenal gland]. Vopr Onkol (2002) 0.75
[Biochemical and morphological patterns of blood platelets in Glanzman-Naegeli disease]. Vopr Med Khim (1967) 0.75
[A difficult way to diagnosis sarcoidosis]. Ter Arkh (2006) 0.75
[The prolymphocytic-lymphocytic leukemization of T-cell lymphosarcomas]. Ter Arkh (1995) 0.75
[Argyrophilic proteins of nucleolar organizers regions as markers of malignancy grade of anaplastic large-cell lymphoma and Hodgkin's lymphoma]. Arkh Patol (2004) 0.75
[Neuropathic hemorrhagic diathesis]. Ter Arkh (1969) 0.75
[Lymphoproliferative diseases of the orbit and appendages of the eye]. Arkh Patol (2001) 0.75
[Ultrastructural criteria of clinical prognosis in hormonally non-active adrenocortical tumors]. Vopr Onkol (2003) 0.75
[MALT-lymphomas in Sjogren's disease]. Ter Arkh (2006) 0.75
[Atypical course of Marchiafava-Micheli syndrome]. Ter Arkh (1967) 0.75
[Pathogenesis and treatment of Marchiafava-Micheli disease]. Probl Gematol Pereliv Krovi (1968) 0.75
[Prognostic importance of distinguishing lymphosarcoma variants by the WHO classification]. Gematol Transfuziol (1983) 0.75
[On determination of porphobilinogen in urine]. Lab Delo (1966) 0.75
[Combined treatment of acute leukemia]. Probl Gematol Pereliv Krovi (1967) 0.75
[Argyrophilic proteins in the regions of nucleolar organizers are markers of cell proliferation rate]. Arkh Patol (2006) 0.75
[Primary hepatic lymphoma in a female patient with Sjögren's disease: A case report and literature review]. Ter Arkh (2015) 0.75